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Abstract
The National Health Service (NHS) is facing financial constraints and thus there is considerable interest in ensuring the shortest but
optimal hospital stays possible. The aim of this study was to investigate patterns of postoperative length of stay (LOS) stay across the
English NHS and to identify factors that significantly influence both optimal and prolonged LOS.
Data were obtained from the National Cancer Data Repository (NCDR). National patterns of LOS were examined and multilevel
mixed effects logistic regression was used to study factors associated with an “ideal” (5 days) or a prolonged (≥21 days) LOS in
hospital after major resection. Funnel plots were used to examine variation across hospitals in both risk-adjusted and unadjusted
LOS.
All 240,873 individuals who underwent major resection for colorectal cancer were diagnosed between 1998 and 2010 in the
English NHS. The overall median LOSwas 10 (interquartile range [IQR] 7–14 days) days, but it fell over time from 11 (IQR 9–15) days in
1998 to 7 (IQR 5–12) days in 2010. The proportion of people experiencing “ideal” LOS increased dramatically from 4.9% in 1998 to
34.2% in 2010, but the decrease in the proportion of patients who experienced a prolonged LOSwas less marked falling from 11.2%
to 8.4%, respectively. Control charts showed that there was significant variation in short and prolonged LOS across NHS trusts even
after adjustment for case-mix.
Significant variation in LOS existed between NHS hospitals in England throughout period 1998 to 2010. Understanding the
underlying causes of this variation between surgical providers will make it possible to identify and spread best practice, improve
services, and ultimately reduce LOS following colorectal cancer surgery.
Abbreviations: CI = Confidence Interval, HES = Hospital Episode Statistics, ICD10 = International Classification of Diseases
Version 10, IMD = Index of Multiple Deprivation, IQR = Interquartile range, LOS = Length of stay, MDT = Multidisciplinary team,
NCDR = National Cancer Data Repository, NHS = National Health Service, OR = Odds Ratio.
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Colorectal cancer is a common disease in the UK with over
41,000 new cases diagnosed each year.[1] The cost of diagnosingEditor: Mohammad Derakhshan.
Source of Funding: Leeds Medical Research Council Medical Bioinformatics
Centre (MR/L01629X/1).
AA is the joint senior author
Data for this study are based on information collected and quality assured by the
PHE National Cancer Registration and Analysis Service. Access to the data was
facilitated by the PHE Office for Data Release.
The authors report no conflicts of interest.
a Cancer Epidemiology Group, Section of Epidemiology and Biostatistics, Leeds
Institute of Cancer & Pathology, University of Leeds, b Knowledge and
Intelligence Team (Northern & Yorkshire), c National Cancer Registration Service
(Northern & Yorkshire), Public Health England, d Leeds Institute of Cancer &
Pathology, University of Leeds, St James’s University Hospital, Leeds, UK.
∗
Correspondence: to Ariadni Aravani, room 6.06, Clinical Sciences Building, St
James’s University Hospital, Leeds LS9 7TF, UK (e-mail: A.Aravani@leeds.ac.uk).
Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All
rights reserved.
This is an open access article distributed under the Creative Commons
Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Medicine (2016) 95:47(e5064)




and treating these patients is considerable, and as the National
Health Service (NHS) is facing significant funding constraints,[3]
organizing services to be both high-quality and cost-effective is
important. Colorectal cancer is predominantly treated surgically
and the major expense in managing the disease is associated with
resection of the tumour and the associated postoperative length
of stay (LOS).[2] There is considerable interest, therefore, in
ensuring the shortest hospital stays and the NHS has invested,
among other initiatives, in minimally invasive surgery and
enhanced recovery programmes to optimize surgical pathways.[4]
The length of time an individual spends in hospital following
their surgery has been suggested as amarker of the quality of care.
The accepted “ideal” LOS resulting from optimal surgery and
enhanced recovery programmes is deemed to be 5 days or fewer.
The proportion of individuals with hospital stays at or below this
threshold has been routinely used, therefore, as a measure of
good practice.[5] Conversely, excessive or prolonged LOS has
also been suggested as an indicator of the effectiveness of care.
Overall, however, there is significant interest in monitoring
hospital stays and publishing comparative analyses across the
different multidisciplinary teams (MDTs) providing care in an
effort to improve standards. Reliably identifying institutions with
“outlying” practice is, however, difficult for several reasons.[6]
First, numerous factors may influence postoperative LOS
including the age of the patient, the presence of concomitant
disease, the site and stage of the tumour and the method of
presentation, type of operation performed, and whether
[7–11]
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very different characteristics and so robust comparison demands
the differing balance of these factors to be incorporated in “risk-
adjusted” analyses. Furthermore, the annual number of patients
operated for colorectal cancer differs between hospitals. Greater
variability in LOS may be observed among hospitals with lower
workloads compared to those with higher workloads simply by
chance. Thus, appropriate adjustment for workload must be
undertaken to reliably compare providers. Finally, national
comparisons demand national population-based data containing
information on factors likely to influence LOS. These have only
relatively recently become available in the National Cancer Data
Repository (NCDR).[12,13] This is a resource that includes linked
cancer registry (CR) and Hospital Episode Statistics (HES) data.
This study aims, therefore, to make use of these data and apply
robust methods to investigate patterns of postoperative LOS stay
across the English NHS. It seeks to identify factors that
significantly influence both optimal and prolonged LOS and
make risk-adjusted comparisons between all providers treating
this disease, with the ultimate purpose of feeding these
information back to Trusts to enable them to do “root cause
analyses” of LOS.2. Methods
All individuals diagnosed with a first primary colorectal cancer
(International Classification of Diseases Version 10 [ICD-10]
C18-C20)[14] between 1998 and 2010, and who had undergone a
major resection[15] for their disease in an NHS hospital, were
identified, in the NCDR. Information on date of diagnosis, age,
sex, deprivation (measured via the income domain of the Index of
Multiple Deprivation [IMD] 2004), site of tumour, and Dukes’
stage were extracted from the cancer registry dataset. Informa-
tion on the type of surgery, date of surgery, and allocation of
patients into Trusts were derived, using standard algo-
rithms,[12,15] from the HES component of the NCDR.
A Charlson comorbidity index[16] was derived for each
individual in the cohort, taking into account diagnoses (excluding
cancer) from any hospital admissions in the year before the
diagnosis of colorectal cancer. The cancer component of the
Charlson index was derived from the cancer registry information
found in NCDR and the score for any other cancers in the year
before colorectal cancer was added to the score obtained from
HES data. The Charlson score was categorized as: 0, 1, 2, and ≥3
with higher scores indicating greater comorbidity.
LOS was defined as the time from the date of major resection to
the date of discharge or death, whichever came first. Individuals
with a negative LOS (due to errors in dates recorded in the routine
data) were excluded. Individuals experiencing the optimal stay of
5 (including the day of discharge but excluding those who died
within this time) were identified as were those with a prolonged
LOS ≥90th percentile (21 days). The overall median LOS and the
proportion of individuals in both the optimal and prolonged LOS
categories were then calculated by the patient and management
characteristics of age, year of diagnosis, sex, IMDcategory, tumour
site, admission method, Charlson comorbidity score, Dukes’ stage
of disease at diagnosis, and operation type (emergency/elective).
Variation in LOS in relation to the approach to surgery (open,
laparoscopic or laparoscopic conversion) was also investigated but
as laparoscopic procedures were not consistently coded in HES
before2006 theseanalyseswere limited to cases diagnosedafter this
time.Mann–Whitney,x2, or t testswereused to assess the statistical
significance of any differences in LOS.2
Dukes’ stage of disease is an important prognostic factor in
colorectal cancer, but information was missing for this factor
from 12% of cases. Analysis based on complete data only would
restrict the assessment of LOS to 88% of the patients introducing
a risk of bias and loss of information. These missing data were
imputed,[17] therefore, using the ICE command in Stata (Version
13.1), an iterative multivariable regression technique, using
ordered logistic regression with 5 imputations and 10 cycles of
regression switching. Dukes’ stage data were assumed to be
“missing at random” (MAR), which means that given the
observed data, the missingness mechanism does not depend on
the unseen data. The MAR assumption is possible because all the
variables included in the analyses or potentially predictive of
Dukes’ stage missing values were included in the imputation
model.
The imputation model consisted of variables: Length of
hospital stay, age at diagnosis, sex, workload of the trust, Dukes’
stage, IMD income category, tumour site, year of diagnosis, year
of major resection, admission method (elective or emergency),
Charlson comorbidity score, hospital of management, and cancer
registry region. The models used to assess prolonged LOS were
applied to both the complete dataset and the imputed dataset for
sensitivity analysis purposes.
Two models were used to identify factors associated with both
the ideal and prolonged LOS. These were multilevel mixed effects
logistic regression with a hierarchy of patients (level 1) nested
within hospitals (level 2). The response variable was either the
ideal or prolonged LOS. Explanatory variables in the risk-
adjusted model were age at diagnosis, sex, IMD income category,
tumour site, year of diagnosis, Charlson comorbidity score,
Dukes’ stage at diagnosis, type of operation (elective or
emergency), and approach to surgery (open, laparoscopic, and
converted). The results are presented as an odds ratio (OR) with
95% confidence interval (CI) for each explanatory variable. OR
is the ratio of the odds of the event of interest (i.e., postoperative
LOS <5 days) in one group (i.e., females) over the odds of the
event of interest in the baseline group (i.e., males).
Funnel plots were used to compare both ideal and prolonged
LOS rates between trusts, using the Spiegelhalter approach.[18]
Ideal and prolonged LOS ratios were calculated for each MDT
from each individual’s probability of staying in hospital in the
defined periods, derived from models based on the imputed
dataset. Ideal and prolonged LOS rates were then calculated by
multiplying the MDT-specific ratios by the average national rates
(shown as a horizontal line on the funnel plots). These MDT-
specific ratios were then plotted against MDT surgical workload
(number of major resections in the study period) using the
“funnelcompar” command in Stata with 95% (inner line) and
99.8% (outer line) control limits. Laney’s approach[19] was used
to deal with overdispersion. MDTs with rates outside the 99.8%
control limits were considered to be “outliers.”
Ethical approval for this study was obtained from East
of Scotland Research Ethics Committee Reference (No. 08/
S0501/66).3. Results
A total of 243,558 individuals were identified as having
undergone a major resection for a first primary bowel cancer
diagnosed between 1998 and 2010 in one of 150 English MDTs.
Of these, 2685 had dates of discharge that were before their date
of major resection giving a negative LOS. These individuals were,
therefore, excluded leaving a full study population of 240,873. As
Figure 1. Changes in median, ideal, and prolonged length of stay over time.
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2006 onwards the study population for analyses investigating the
use of laparoscopy was limited to the eligible 99 100 diagnosed
and managed post that date.
The overall median LOS for the 1998 to 2010 and 2006 to
2010 study periods were 10 (interquartile range [IQR] 7–14 days)
and 8 (IQR 5–13) days, respectively (Fig. 1), but over time there
were significant changes in practice. Although the overall median
LOS decreased gradually falling from 11 (IQR 9–15) days in
1998 to 7 (IQR 5–12) days in 2010 the proportion of the
population who experienced a short “ideal” LOS increased
dramatically from 4.9% in 1998 to 34.2% in 2010 (Table 1 and
Fig. 1). The reduction in the proportion of patients who
experienced a prolonged LOS was much less marked falling from
11.2% to 8.4% over the same period. LOS also varied
considerably in relation to the characteristics of the population
(Table 1). Overall median LOS increased with increasing age (12
days [IQR 7–18] for those >80 years vs. 8 days [IQR (6–12] for
those aged 50) and socioeconomic deprivation (11 days [IQR
7–16] for those living in the most deprived areas versus 9 days
(IQR 7–14) for those in the most affluent areas) and was longer
for those with rectal cancer (11 days [IQR 8–16]) compared to
colon cancer (9 days [IQR 6–14]).
In the 1998 to 2010 analysis, the proportion of people
experiencing an “ideal” LOS was greatest in those in younger age
(21.1% in those 50 vs. 13.6% in those >80, P<0.001), the
more socioeconomically affluent (16.8% in the most affluent
group versus 13.8% in the most deprived, P<0.001), in those
with colon cancer rather than rectal cancer (17.6% vs. 12.0%,
P<0.001), in those with early stage disease (17.3% in Dukes A
patients versus 15.1% in stage D, P<0.001) and in those who did
not have a stoma formed at major resection (17.7% vs. 11.9%,
P<0.001). The formation of stoma is associated with the cancer
site, with 69% of patients diagnosed with rectal cancer getting a
stoma in contrast to the 31% of those who were diagnosed with
colon cancer. The relationship with comorbidity was complex. In
the 1998 to 2010 analysis, the proportion experiencing an
optimal LOS increased with increasing Charlson comorbidity3
scores, but in the 2006 to 2010 analysis, the effect was reversed.
This may be related to the improvements in comorbidity
recording in routine data over time. There was no clinically
significant difference in the proportion having an optimal stay in
relation to operation type in the 1998 to 2010 analysis (15.9%
for elective operation versus 15.4% for emergencies, P<0.001
[statistically significant difference owing to large group sizes]),
but in the 2006 to 2010 analysis, a significant greater proportion
of elective patients experienced a short hospital stay (27.3% vs.
21.9%, P<0.001).
In the 1998 to 2010 analysis, the proportion of people
experiencing a prolonged LOS was greatest in those in older age
groups (17.3% in those >80 compared to 5.4% in those 50,
P<0.001), the more socioeconomically deprived (13.4% in
those living in the most deprived areas vs. 9.3% in the most
affluent P<0.001) and more comorbid groups (17% in Charlson
score ≥3 vs. 10% in Charlson score 0, P<0.001) and was also
elevated in those who underwent emergency surgery (16.4% vs.
9.2%, P<0.001). Prolonged LOS was also more common in
individuals with rectal rather than colonic tumors (13.4% vs.
9.7%, P<0.001) and in those who had a stoma formed at major
resection (15.9% vs. 8.3%, P<0.01).
The results of the model investigating the odds of an optimal
LOS for the period 2006 to 2010 are shown in Table 2. Factors
associated with reduced odds of an optimal LOS included
increasing age (OR 0.81 95% CI 0.79–0.82, P<0.001),
increasing socioeconomic deprivation (OR 0.81 95% CI
0.77–0.86, P<0.001 for the most deprived category versus the
most affluent), having a rectal tumour (OR 0.49 95% CI
0.47–0.51, P<0.001 compared to a colon tumour),
being admitted as an emergency (OR 0.88 95% CI 0.84–0.91,
P<0.001 for emergency procedures versus elective), higher levels
of comorbidity (OR 0.87 95% CI 0.79–0.95, P<0.001 for
Charlson score ≥3 vs. 0), with increasing stage at disease (OR
0.91 95% CI 0.85–0.98, P<0.001 Dukes D compared to Dukes
A). In contrast, the odds of an optimal LOS increased significantly
over time (OR 1.17 [per year] 95%CI 1.16–1.19, P<0.001) and
in those undergoing laparoscopic surgery (OR 3.58 95% CI
Table 1
Characteristics of the study population in relation to length of stay.
Characteristic
1998–2010 2006–2010
Length of stay, days Length of stay, days
<6 >21 <6 >21
Total population n % n % Median IQR Total population n % n % Median IQR
Age at diagnosis
50 14,657 3090 21.10 794 5.40 8 6–12 6312 2060 32.60 321 5.09 7 5–10
51–60 33,008 5491 16.60 2100 6.40 9 7–12 13,254 3847 29.00 784 5.92 7 5–11
61–70 67,645 11,642 17.20 5516 8.20 9 7–13 29,094 8569 29.50 2068 7.11 7 5–12
71–80 83,848 12,223 14.60 10,443 12.50 10 7–15 33,028 8016 24.30 3511 10.63 8 5–13
>80 41,715 5664 13.60 7219 17.30 12 7–18 17,412 3493 20.10 2460 14.13 10 6–16
Sex
Male 133,650 21,350 16.00 14,707 11.00 10 7–14 55,406 14,352 25.90 5368 9.69 8 5–13
Female 107,223 16,760 15.60 11,365 10.60 10 7–14 43,694 11,633 26.60 3776 8.64 8 5–12
IMD income category
Most affluent 48,920 8196 16.80 4554 9.30 9 7–14 21,230 5892 27.80 1758 8.28 8 5–12
2 53,405 8792 16.50 5224 9.80 10 7–14 22,400 6140 27.40 1872 8.36 8 5–12
3 51,551 8504 16.50 5449 10.60 10 7–14 21,359 5748 26.90 1884 8.82 8 5–13
4 47,166 7137 15.10 5492 11.60 10 7–15 18,808 4794 25.50 1859 9.88 8 5–13
Most deprived 39,831 5481 13.80 5353 13.40 11 7–16 15,303 3411 22.30 1771 11.57 9 6–14
Tumor site
Colon 157,248 27,620 17.60 15,264 9.70 9 6–14 66,046 19,198 29.10 5501 8.33 7 5–12
Rectosigmoid 19,367 2760 14.30 2179 11.30 10 7–15 7372 1853 25.10 743 10.08 8 5–13
Rectum 64,258 7730 12.00 8629 13.40 11 8–16 25,682 4934 19.20 2900 11.29 9 6–14
Year of diagnosis
1998 17,739 861 4.90 1985 11.20 11 9–15 — — — — — — —
1999 17,899 957 5.30 2079 11.60 11 9–15 — — — — — — —
2000 17,857 1063 6.00 2200 12.30 11 8–16 — — — — — — —
2001 17,174 1298 7.60 2235 13.00 11 8–16 — — — — — — —
2002 17,302 1571 9.10 2099 12.10 11 8–15 — — — — — — —
2003 17,430 1682 9.70 2131 12.20 11 7–15 — — — — — — —
2004 17,979 2089 11.60 2226 12.40 10 7–14 — — — — — — —
2005 18,393 2604 14.20 1973 10.70 10 6–14 — — — — — — —
2006 18,765 3315 17.70 1890 10.10 9 6–14 18,765 3315 17.70 1890 10.07 9 6–14
2007 19,315 4173 21.60 1820 9.40 8 6–13 19,315 4173 21.60 1820 9.42 8 6–13
2008 19,988 5342 26.70 1842 9.20 8 5–13 19,988 5342 26.70 1842 9.22 8 5–13
2009 20,361 6082 29.90 1852 9.10 7 5–12 20,361 6082 29.90 1852 9.10 7 5–12
2010 20,671 7073 34.20 1740 8.40 7 5–12 20,671 7073 34.20 1740 8.42 7 5–12
Charlson comorbidity score
0 190,361 29,565 15.50 18,999 10.00 10 7–14 74,900 20,318 27.10 6165 8.23 8 5–12
1 33,787 5612 16.60 4445 13.20 10 6–15 15,765 3735 23.70 1752 11.11 8 5–14
2 10,981 1899 17.30 1652 15.00 10 6–16 5419 1250 23.10 737 13.60 9 5–15
≥3 5744 1034 18.00 976 17.00 10 5–18 3016 682 22.60 490 16.25 9 5–17
Dukes’ Stage at diagnosis
A 28,126 4852 17.30 2642 9.40 9 7–14 13,099 3723 28.40 1014 7.74 8 5–12
B 81,002 12,867 15.90 8714 10.80 10 7–14 34,210 8974 26.20 3200 9.35 8 5–13
C 80,531 12,776 15.90 8792 10.90 10 7–14 33,806 8832 26.10 3134 9.27 8 5–13
D 21,314 3226 15.10 2393 11.20 10 7–15 8818 2208 25.00 867 9.83 8 5–13
Unknown 29,900 4389 14.70 3531 11.80 10 7–15 9167 2248 24.50 929 10.13 8 5–13
Operation type
Elective 185,482 29,574 15.90 16,972 9.20 10 7–14 86,056 21,684 27.30 7315 8.50 8 5–12
Emergency 55,391 8536 15.40 9100 16.40 11 6–17 13,044 4301 21.90 1829 14.02 10 5–16
Approach to surgery
Open 75,128 15,188 20.20 7716 10.27 9 6–14
Laparoscopic 20,344 9935 48.80 1038 5.10 6 4–8
Converted 3628 862 23.80 390 10.75 8 6–13
Stoma formed at major resection
No 161,369 28,615 17.70 13,411 8.30 9 6–13 65,615 20,279 30.90 4501 6.90 7 5–11
Yes 79,504 9495 11.90 12,661 15.90 12 8–17 33,485 5706 17.00 4643 13.90 10 6–15
Total 240,873 38,110 15.82 26,072 10.82 10 7–14 99,100 27,115 27.36 9144 9.23 8 5–13
IMD= Index of Multiple Deprivation, IQR= interquartile range.
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Table 2
Multivariable analysis investigating the odds of an ideal length of stay (2006–2010).
Complete case analysis Multiple imputation analysis
Characteristic OR LCL UCL P OR LCL UCL P
Age at diagnosis (per year), y 0.81 0.80 0.82 <0.01 0.81 0.79 0.82 <0.01
Sex
Male 1.00 1.00
Female 0.97 0.94 1.00 0.08 0.97 0.94 1.00 0.10
IMD income category
Most affluent 1.00 1.00
2 0.95 0.91 1.00 0.05 0.95 0.91 1.00 0.05
3 0.91 0.86 0.95 <0.01 0.90 0.86 0.95 <0.01
4 0.89 0.85 0.94 <0.01 0.89 0.84 0.93 <0.01
Most deprived 0.81 0.77 0.86 <0.01 0.81 0.77 0.86 <0.01
Tumour site
Colon 1.00 1.00
Rectosigmoid 0.77 0.72 0.82 <0.01 0.75 0.71 0.80 <0.01
Rectum 0.49 0.47 0.51 <0.01 0.49 0.47 0.51 <0.01
Year of diagnosis (per advanced year) 1.18 1.16 1.19 <0.01 1.17 1.16 1.19 <0.01
Admission method
Elective 1.00 1.00
Emergency 0.82 0.79 0.86 <0.01 0.88 0.84 0.91 <0.01
Co-morbidities
0 1.00 1.00
1 0.88 0.84 0.92 <0.01 0.88 0.84 0.92 <0.01
2 0.90 0.84 0.97 0.01 0.89 0.83 0.95 <0.01
≥3 0.87 0.79 0.96 0.01 0.87 0.79 0.95 <0.01
Dukes’ Stage at diagnosis 1.00 1.00
A 1.00 1.00
B 0.93 0.89 0.98 0.01 0.93 0.89 0.98 0.01
C 0.95 0.90 1.00 0.05 0.95 0.90 1.00 0.05
D 0.91 0.85 0.97 0.01 0.91 0.85 0.98 0.01
Approach to surgery
Open 1.00 1.00
Laparoscopic 3.60 3.46 3.75 <0.01 3.58 3.45 3.72 <0.01
Converted 1.04 0.96 1.14 0.34 1.06 0.97 1.15 0.19
IMD= Index of Multiple Deprivation, LCL= lower confidence limit, OR= odds ratio, UCL=upper confidence limit.
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statistically significant difference in the odds of having an ideal
LOS in those whose laparoscopic surgery was converted to open
surgery (OR 1.06 95% CI 0.97–1.15, P=0.185).
This model was used to generate risk-unadjusted and risk-
adjusted funnel plots investigating the proportion of patients
experiencing an optimal LOS across all the English colorectal
MDTs managing these patients (Fig. 2A and B). Thirteen
MDTs had significantly higher risk-unadjusted rates and 7
MDTs had significantly higher risk-adjusted rates of ideal LOS
than was expected (i.e., outside the upper 99.8% control limit).
The equivalent figures for the risk-unadjusted and adjusted
analyses for lower rates than expected were 2 and 4 MDTs,
respectively.
Conversely, the results of the model investigating the odds of a
prolonged LOS for period 2006 to 2010 are shown in Table 3.
The odds of a prolonged LOS were statistically significantly
greater in the elderly (OR 1.14 95% CI 1.38–1.44, P<0.001 per
year increase in age), in those residing in more socioeconomically
deprived areas (OR 1.28 95% CI 1.19–1.39, P<0.001 for those
most deprived category compared to the most affluent), in those
with rectal tumors (OR 2.04 95% CI 1.93–2.15, P<0.001 for
rectal tumors compared to colon), in those presenting as an
emergency (OR 2.10 95% CI 1.99–2.22, P<0.001), in those
with greater comorbidity (OR 1.66 95%CI 1.50–1.85, P<0.0015
for Charlson score ≥3 vs. 0) and with increasing stage at disease
(OR 1.13 95% CI 1.01–1.27, P=0.025 for Dukes D vs. Dukes
A). The odds of a prolonged LOS was significantly reduced in
those undergoing laparoscopic surgery (OR 0.55, 95% CI
0.51–0.59, P<0.001) but was increased in those who underwent
laparoscopic surgery that was converted to open surgery (OR
1.19, 95% CI 1.06–1.33, P<0.001).
Twelve MDTs had a statistically significantly greater propor-
tion of patients experiencing a prolonged LOS than would be
expected in the risk-adjusted and unadjusted analyses respective-
ly (Fig. 3A and B). In contrast, 12 and 11MDTs had a statistically
significantly lower rate of patients experiencing a prolonged LOS
than was expected in the risk-adjusted and -unadjusted analyses,
respectively.
4. Discussion
This retrospective population-based study comprehensively
quantifies patterns of postoperative LOS following major
colorectal cancer surgery across the English NHS. The study
shows that over a 13-year period, the overall median LOS has
statistically significantly reduced. This is in large part because of a
major increase in the proportion of people experiencing an
optimal LOS of 5 days, which was promoted as a measure
of good care after the introduction of enhanced recovery
[5,20–23]
Figure 2. (A) Risk-unadjusted short length of stay by NHS trust for patients with colorectal cancer who underwent a major resection: England, patients diagnosed
between 2006 and 2010. (B) Risk-adjusted short length of stay (adjusted for age, sex, deprivation, tumour site, year of diagnosis, admission method, Charlson
comorbitidy score, Dukes’ stage, and approach to surgery).
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reduction in the proportion of people experiencing a prolonged
LOS of ≥21 days. In addition, there was significant variation
across the population with LOS proving longer in the elderly,
those living in socioeconomically deprived areas, with rectal
cancers, with greater comorbid disease and in those admitted as
an emergency. LOS was statistically significantly reduced in those
whose surgery was successfully undertaken laparoscopically.Table 3
Multivariable analysis investigating the odds of a prolonged length o
Complete case analysis
Characteristic OR LCL UCL
Age at diagnosis (per year) 1.40 1.37 1.43
Sex
Male 1.00
Female 0.88 0.84 0.93
IMD income category
Most affluent 1.00
2 1.02 0.95 1.10
3 1.08 1.00 1.16
4 1.19 1.10 1.28
Most deprived 1.32 1.22 1.43
Tumour site
Colon 1.00
Rectosigmoid 1.56 1.43 1.70
Rectum 2.09 1.97 2.22
Year of diagnosis (per advanced year) 0.99 0.97 1.01
Admission method 1.00
Elective
Emergency 2.15 2.03 2.27
Co-morbidities
0 1.00
1 1.22 1.15 1.30
2 1.42 1.30 1.56
≥3 1.75 1.57 1.95
Dukes’ Stage at diagnosis
A 1.00
B 1.14 1.05 1.23
C 1.11 1.02 1.20
D 1.14 1.03 1.26
Approach to surgery
Open 1.00
Laparoscopic 0.54 0.50 0.59
Converted 1.21 1.07 1.36
IMD= Index of Multiple Deprivation, LCL= lower confidence limit, OR= odds ratio, UCL=upper confide
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Statistically significant variation, independent of case mix was
also observed between the colorectal MDTs. Given that the
average cost per bed-day for a person undergoing colorectal
cancer surgery is £441, according to the MRC Conventional
versus Laparoscopic-Assisted Surgery in Colorectal Cancer trial
(CLASSIC),[24] a median LOS reduction from 11 days in 1998 to
7 days in 2010 saved the NHS an estimated £1 764 per patient
(around £32 M per year on average).f stay (2006–2010).
Multiple imputation analysis
P OR LCL UCL P
<0.01 1.41 1.38 1.44 <0.01
1.00
<0.01 0.88 0.84 0.92 <0.01
1.00
0.54 1.02 0.95 1.10 0.55
0.06 1.08 1.01 1.16 0.03
<0.01 1.18 1.10 1.27 <0.01
<0.01 1.28 1.19 1.39 <0.01
1.00
<0.01 1.53 1.41 1.67 <0.01
<0.01 2.04 1.93 2.15 <0.01
0.32 0.99 0.97 1.01 0.21
1.00
<0.01 2.10 1.99 2.22 <0.01
1.00
<0.01 1.22 1.15 1.30 <0.01
<0.01 1.45 1.34 1.59 <0.01
<0.01 1.66 1.50 1.85 <0.01
1.00
<0.01 1.12 1.04 1.21 <0.01
0.01 1.10 1.01 1.19 0.03
0.01 1.13 1.01 1.27 0.03
1.00
<0.01 0.55 0.51 0.59 <0.01
<0.01 1.19 1.06 1.33 <0.01
nce limit.
Figure 3. (A) Risk-unadjusted prolonged length of stay by NHS trust for patients with colorectal cancer who underwent a major resection: England, patients
diagnosed between 2006 and 2010. (B) Risk-adjusted prolonged length of stay (adjusted for age, sex, deprivation, tumour site, year of diagnosis, admission
method, Charlson comorbitidy score, Dukes’ stage, approach to surgery).
Aravani et al. Medicine (2016) 95:47 www.md-journal.comThe overall median LOS is broadly comparable to that shown
in other UK studies. For example, the National Bowel Cancer
Audit Programme, which captures data submitted voluntarily by
the majority of hospitals in the UK, reported a comparable
median LOS of seven and nine days for colon and rectal cancer
patients, respectively.[5] Another study based on all elective
malignant and nonmalignant colorectal surgeries across the same
population did, however, report a longer median LOS.[9] This is
unexpected given that study was limited to elective surgery and
included nonmalignant operations too. It is not clear why their
findings are discrepant, but it may be a result of the use of total
LOS rather than the definition used here of postoperative LOS.
The relevant total LOS derived from the 2 studies are broadly
comparable (results not shown). The LOS for English patients
also appears to compare relatively favorably to equivalent
international figures.[8,10,25]
The findings of this study support those previously
published[26–29] that indicate there are numerous characteristics
that consistently influence LOS. For example, longer hospitals
stays were associated with increasing patient age, comorbidity,
socioeconomic deprivation, stage of disease, and following
emergency operations. The risk of surgery increases with many of
these factors and greater surgical challenge would logically
predispose to greater recovery times. Furthermore, the longest
stays were observed in those undergoing surgery for rectal cancer.
This is a result of the fact that postoperative stays of individuals
receiving stomas, which currently rectal cancers demand more
frequently, are longer by a median of 3 days than those of people
who are able to maintain the continuity of the bowel.
A potential limitation of the study is that the case-mix
adjustment was inadequate because of the routine nature of the
data analyzed. For example, the Charlson index was used as a
measure of comorbidity. Although this index is able to robustly
predict prognosis and, consequently, is used routinely to assess
the influence of comorbidity in many population-level analyses, it
is a relatively crude measure, as it only incorporates information
on illness that necessitated a hospital stay in the year before
diagnosis. Individuals may possess other comorbidities that still
have an important influence on surgical outcomes but the routine
data available in the NCDR does not yet allow these to be reliably
identified and taken into consideration. In addition, the quality of
coding in routine hospital data has improved over time leading to
changes in the comorbidity information the Charlson Index relies
on. (This may explain the unusual and opposing relationship of
Charlson score and the proportion of people experiencing an7
ideal LOS in the 1998–2010 and the 2006–2010 analyses.)
Likewise, a person’s socioeconomic status should not influence
the rate at which they recover from an operation but those living
in more deprived areas are perhaps more likely to have unhealthy
lifestyles and so pose a greater surgical risk and require a longer
recuperation time or have social reasons for delayed discharge.
Again the availability of more detailed case-mix information
could significantly improve the strength of the results.
Another potential limitation of the study is its failure to take
into account other outcomes related to LOS. For example, a rapid
discharge may be inappropriate if the patient has not sufficiently
recovered and, consequently, is rapidly re-admitted. Likewise,
rapid postoperative deaths will positively influence LOS, but are a
negative outcome. The methodology was adapted to ensure those
who died rapidly postsurgery were excluded from the optimal
LOS category, but a high number of postoperative deaths will,
nevertheless, still reduce an MDT’s overall LOS and this should
be considered in any hospital level comparative analyses. No
changes were made to the methodology to account for re-
admission rates, but the routine data this study is based on would
allow for this to be quantified and future analyses are, therefore,
proposed in this area.
In an effort to increase the efficiency of services the NHS has, in
recent years, made reducing LOS a priority. This study suggests
that the numerous interventions adopted to reduce LOS,
including the roll out of laparoscopic surgery[30] and enhanced
recovery programmes[4] have had a significant impact. Although
these interventions rapidly rolled out between 2006 and 2010
there is not an accurate way of recording whether or not the
hospital has applied the concept of enhanced recovery. Overall
median LOS has dropped and the proportion of patients
experiencing an optimal stay has increased significantly. There
has, however, been a much less marked reduction in the
proportion of individuals experiencing a prolonged LOS. This
may suggest that although initiatives to reduce LOS are effective,
there remains a stubborn population of high-risk patients whose
postoperative recovery times are likely to be substantial. Further
quantification of the characteristics of this population would
provide useful evidence to help develop future management
strategies that could reduce the LOS for this group, such as
screening or increase of colorectal cancer resections. However,
with the aging population, it could also be anticipated that the
proportion of individuals with comorbidity and other negative
prognostic factors will increase resulting in a tendency for
average LOS to increase. The optimization of diagnostic and
[15] Morris EJ, Taylor EF, Thomas JD, et al. Thirty-day postoperative
Aravani et al. Medicine (2016) 95:47 Medicinetreatment strategies will be required to meet this challenge and
ensure an optimal postoperative LOS.References
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